최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한위암학회지 = Journal of the Korean Gastric Cancer Association, v.9 no.3 = no.35, 2009년, pp.136 - 142
김사영 (한양대학교 의과대학 외과학교실) , 하태경 (한양대학교 의과대학 외과학교실) , 권성준 (한양대학교 의과대학 외과학교실)
Purpose: This clinical study was conducted to evaluate the predictive value of tumor markers for recurrence and the clinical significance of false positive findings after curative gastrectomy in patients with gastric cancer. Materials and Methods: Two hundred ninety patients with gastric cancer who ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002;49:1157-1160.
Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H. Tumor Marker Committee. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003;6:142-145.
Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD. The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 2004;51:1544-1547.
Choi SR, Jang JS, Lee JH, Roh MH, Kim MC, Lee WS, Qureshi W. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci 2006;51:2081-2086.
Nakamura N, Aoji O, Yoshikawa T, Mori K, Kajiyama S, Yoshihiro K, Kanatsuna T, Kondo M. Elevated serum CA19-9 levels in poorly controlled diabetic patients. Jap J Med 1986;25:278-280.
Marechal F, Berthiot G, Deltour G. Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res 1988;8:677-680.
Nomura F, Koyama A, Ishijima M, Takano S, Narita M, Nakai T. Serum levels of five tumor markers for lung cancer in patients with chronic renal failure. Oncol Rep 1998;5:389-392.
Giannini E, Borro P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romaqnoli P, Testa E, Risso D, Lantieri PB, et al. Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis. Int J Biol Markers 2000;15:226-230.
Ohtsuka T, Sato S, Kitajima Y, Tanaka M, Nakafusa Y, Miyazaki K. False-positive findings for tumor markers after curative gastrectomy for gastric cancer. Dig Dis Sci 2008;53:73-79.
Yook JH, Kim BS, Kim YH, Suh BS, Kim WS, Oh ST, Park KC. Diagnostic value of tumor markers in stomach cancer. J Korean Cancer Assoc 1999;31:1094-1100.
Joypaul B, Browning M, Newman E, Byrne D, Cuschieri A. Comparison of serum CA 72-4 and C 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995;169:595-599.
Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. The prognostic value of preoperative serum levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gastroenterol 1996;91:49-53.
Ohuchi N, Takahashi K, Matoba N, Sato T, Taira Y, Sakai N, Masuda M, Mori S. Comparison of serum assay for TAG-72, CA 19-9 and CEA in gastrointestinal carcinoma patients. Jpn J Clin Oncol 1989;19:242-248.
Koga S, Kishimoto H, Tanaka K, Kawagushi H. Clinical and pathological evaluation of patients with recurrence of gastric cancer more than five years postoperatively. Am J Surg 1978;136:317-321.
Takeuchi H, Kakeji Y, Tokunaga E, Koga T, Maehara Y, Sugimachi K. Prediction of recurrence after curative resection of gastric carcinoma invading the muscularis propria: a multiple analysis. Gastric cancer 2000;3:28-32.
Kim HI, Kim CS, Kim SJ, Mok YJ, Park SS. Risk factors of the recurrence after a curative resection of gastric carcinoma invading the muscularis propria. J Korean Surg Soc 2006;70:98-101.
Kim SK, Noh SH, Yoo CH, Kim YI, Min JS, Lee KS. Characteristics and prognosis in gastric cancer with liver metastasis. J Korean Cancer Assoc 1997;29:1085-1093.
Kunieda K, Saji S, Sugiyama Y, Osada S, Sano J, Nagao N, Takahashi T, Takagi Y, Arai Y. Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors. Surg Today 2002;32:587-593.
Tobe T, Kouchi M, Tanimura H, Huang CH. Hyperglycemia after gastrectomy as a prediabetic state. Clinical study of 100 postgastrectomy patients. Arch Surg 1967;94:836-840
Sudo T, Ishiyama K, Takemoto M, Kawamura M, Umemura H, Shiraha S, Kuyama T, Suzuki T, Tobe T. Pancreatic endocrine function after tota; gastrectomy and truncal vagotomy. Am J Surg 1982;144:539-544.
Shaffer EA. The effect of vagotomy on gallbladder function and bile composition in man. Ann Surg 1982;195:413-418.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.